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Abstract
Cells have evolved a variety of mechanisms to regulate the enormous complexity of processes 
taking place inside them. One mechanism consists in tightly controlling the localization of 
macromolecules, keeping them away from their place of action until needed. Since a large fraction 
of the cellular response to external stimuli is mediated by gene expression, it is not surprising that 
transcriptional regulators are often subject to stimulus-induced nuclear import or export. Here we 
review recent methods in chemical biology and optogenetics for controlling the nuclear 
localization of proteins of interest inside living cells. These methods allow researchers to regulate 
protein activity with exquisite spatiotemporal control, and open up new possibilities for studying 
the roles of proteins in a broad array of cellular processes and biological functions.
Introduction
Many cellular processes are naturally regulated via control of nuclear import and export [1]. 
For instance, gene transcription is often repressed by sequestering transcription factors in the 
cytosol [2]. To enter and exit the nucleus, macromolecules dynamically interact with nuclear 
transport receptors which facilitate passage through nuclear pore complexes [3,4]. The 
interaction between cargo molecules and the transport receptors is frequently mediated by 
short linear motifs on the cargo called nuclear localization signals (NLS) or nuclear export 
signals (NES) [3,5]. The discovery of these interactions and the control mechanisms that 
regulate them is enabling new technologies which allow cell biologists to manipulate when 
and where proteins enter the nucleus. These inducible systems offer a powerful alternative to 
traditional gene knock-out or RNA knock-down approaches for studying dynamic processes.
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In this review, we briefly describe the protein interactions that mediate nucleocytoplasmic 
transport and provide examples of how these interactions are regulated in natural systems. 
We then present the methods that have been devised for inducible control of nuclear 
localization. These approaches fall into two broad categories: control via small molecules 
and control via light-mediated protein switches (Figure 1). Some of these methods lead to 
non-reversible nuclear accumulation/depletion, while some of the light-based techniques are 
compatible with repeated cycles of import and/or export. Reversible control is particularly 
promising for studying the influence of protein dynamics on cellular decisions. We conclude 
with a perspective on the most important challenges that need to be overcome to permit the 
widespread usage of these tools in research labs.
Nucleocytoplasmic transport
Transport in and out of the nucleus occurs through the nuclear pore complex (NPC) [4,6]. 
Nuclear pore proteins with arrays of phenylalanine-glycine repeats create a permeability 
barrier in the NPC that restricts the flow of proteins through the pore [7,8]. Smaller proteins 
(< 40 kDa) can diffuse through the barrier, while larger proteins require the assistance of 
nuclear transport receptors [9]. Karyopherins are the primary transport receptors used in the 
cell and can act as importins, helping proteins get into the nucleus, or exportins, helping 
proteins leave the nucleus [3]. Karyopherins generally bind to specific linear motifs on their 
transport cargoes.
Importin-α is a karyopherin that binds to nuclear localization signals (NLSs) on cargoes and 
interacts with Importin-β to direct proteins to the nucleus. The sequence and structural 
determinants of binding between Importin-α and NLS motifs have been extensively studied 
[10], and it has been shown that the affinity of Importin-α for a particular NLS influences 
transport efficiencies [11]. NLSs are often short sequences of positively charged lysines and 
arginines. CRM1 (chromosome region maintenance 1, exportin1) is the major nuclear export 
receptor and interacts with nuclear export signals (NESs) that are rich in hydrophobic amino 
acids [12]. Loading and unloading of cargo from the transport receptors is controlled by the 
GTPase Ran [13]. For a more extensive explanation of how nucleocytoplasmic transport 
functions we refer readers to other reviews focused on this topic [10,14,15].
Controlling nuclear localization as a strategy to control protein activity
Most cellular processes need to occur at specific times and locations within a cell for 
accurate and specific cellular function. Therefore, the appropriate proteins need to be 
activated in the right place, at the right time. This can be accomplished by always 
maintaining the proteins in the correct location, but keeping them inactive until needed 
[16,17]. Alternatively, activated proteins can be recruited to the correct location when 
needed [18,19]. Both strategies allow for rapid control as protein activation via post-
translational modification and recruitment can occur much more quickly than transcription 
and translation. Gene expression is a prominent example of a process regulated this way 
[20,21]. Transcription factors and transcriptional co-regulators often are denied access to the 
nucleus where they would find their interacting partners (DNA, co-factors, etc.), remaining 
cytoplasmic until the proper stimuli trigger their nuclear accumulation. Nuclear 
accumulation can also be transient, to allow for adaptation and termination of cellular 
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response. Transient control is achieved by quickly shifting from rapid nuclear import to 
rapid export.
For example, Signal transducer and activator of transcription 1 (STAT1) is a transcription 
factor that is kept in a latent, monomeric form in the cytoplasm in the absence of activating 
signals (cytokines, hormones and growth factors). Upon signal transduction cascade 
initiation, STAT1 is phosphorylated at the plasma membrane by activated kinases (e.g. 
members of the Janus kinase (JAK) family) on a conserved tyrosine at its C- terminus and 
dimerizes [22–25]. Dimer formation induces a conformational change that presents a non-
classical NLS to Importin-α5 leading to transport of phosphorylated, dimeric STAT1 into 
the nucleus [26,27]. Once inside the nucleus, phosphorylated, dimeric STAT1 binds to its 
cognate DNA responsive elements. DNA binding conceals STAT1 NES and prevents its 
dephosphorylation [28], thus nuclear accumulation is further enhanced through repression of 
export.
NF-κB is another example of a transcription factor kept in a latent form in the cytoplasm by 
interaction with its inhibitor IκB. The NF-κB/IκB complex constantly shuttles between the 
nucleus and the cytoplasm, but, since the NES on IκB is stronger than the NLS on NF-κB 
(partly concealed in the complex [29,30]), the resulting localization is heavily shifted 
towards the cytoplasm [31]. Upon arrival of the stimulus onto the cells, IκB gets 
phosphorylated, which leads to its ubiquitination and proteasomal degradation [32]. Once its 
inhibitor is removed, NF-κB can be imported in the nucleus via its fully exposed NLS.
Transcription can also be initiated by exporting repressors out of the nucleus, and terminated 
by re-importing the repressors in the nucleus [33]. For instance, class II histone deacetylases 
HDAC4 and −5 bind to the transcription factor MEF2 turning it into a repressor [34–37]. 
During myogenesis, this repression has to be released to allow transcription of muscle genes. 
This is achieved through export of HDAC4 and −5 from the nucleus. The mechanism 
involves phosphorylation of HDAC5 by calcium-calmodulin-dependent protein kinase 
(CaMK) on two serines (at positions 259 and 498) which triggers binding to the chaperone 
14-3-3 and exposure of the otherwise cryptic NES on HDAC5 [38]. Binding to 14-3-3 may 
additionally block the NLS on HDAC5, thus having two synergistic effects to localize the 
protein to the cytosol [38]. In order for HDAC5 to reenter the nucleus dephosphorylation at 
the two serines is required, likely involving protein phosphatase function in this process.
Importantly, in the last years it is becoming evident that the dynamics of nuclear 
accumulation play a critical role in determining the cellular response to specific stimuli [39–
42]. In order to unravel the importance of these dynamics on determining cellular output, 
methods to reversibly, quickly and precisely control the nuclear localization of proteins of 
interest are needed.
Methods to control nuclear localization
Chemical Control
Discovered in a screen for antifungal antibiotics, leptomycin B (LMB) is a branched-chain 
fatty acid that binds covalently to cysteine 528 on the surface of CRM1 and inhibits binding 
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to NES motifs [43]. Low nanomolar concentrations of LMB are sufficient to induce nuclear 
accumulation of proteins dependent on CRM1 for export, and similar molecules are 
currently being tested for anti-cancer activity [44]. However, LMB is a blunt tool for 
studying the function of individual proteins as it blocks the export of a large set of proteins, 
and long incubation times can lead to the induction of apoptosis or cell cycle arrest.
To control the transport of individual proteins, strategies have been developed that involve 
genetically modifying the protein of interest. Upon ligand binding, class-1 nuclear receptors, 
such as the estrogen receptor (ER), dissociate from heat shock proteins and translocate to the 
nucleus. Taking advantage of this natural mechanism, researchers have fused nuclear 
receptors to proteins of interest (POIs) in order to create ligand-dependent import [45]. In 
some cases, this has required engineering NES and/or NLS in the fusion protein to tune the 
export and import properties of the switch [46,47]. A fusion between ER and Cre 
recombinase is frequently used for inducing site-specific recombination with the ER ligand, 
tamoxifen [48].
Several groups have demonstrated that rapamycin-induced dimerization of the FK506 
binding protein (FKBP) and the FKBP12-rapamycin-binding (FRB) domain of mTOR can 
be used to control the nuclear import or export of POIs (Figure 1) [49–53]. With this strategy 
one half of the dimer system is fused to the POI and the other half is fused to a NLS, NES, 
or to a protein that is known to undergo robust localization to the nucleus or cytosol. In 
Saccharomyces cerevisiae the ribosomal protein Rpl13a has proven effective at directing 
nuclear export as it is abundantly expressed and rapidly transported to the cytoplasm after 
being assembled into ribosomes in the nucleus [51]. Following exposure to rapamycin, the 
target is transported to the cytosol within 15 minutes. Similarly, nuclear import via 
rapamycin-induced recruitment of a FKBP-NLS chimera has been shown to occur in 10–15 
minutes in yeast [50]. These approaches have been used to study a variety of processes 
including transcription [54], spindle positioning [55], and establishment of cell polarity [56]. 
One challenge that can arise when using rapamycin is that will also bind and inhibit 
endogenous mTOR, which can lead to unwanted toxicity. In yeast, this problem can be 
circumvented by using rapamycin-resistant strains that contain a mutated TOR1 and deleted 
FPR1, a yeast homolog to FKBP12 [50,51]. Alternatively, rapamycin analogs (rapalogs) 
have been developed that only bind to mutated forms of FRB [57]. It has been shown that by 
using multiple rapalogs and engineered proteins simultaneously it is possible to direct a POI 
to the nucleus with one rapalog, and to the cytosol with a separate rapalog [58]. For further 
details on chemical dimerization systems we refer readers to other reviews on this topic [59–
61].
Light-inducible control
Irreversible control—Light-inducible control of nuclear transport has gained significant 
interest lately because it offers some advantages when compared to chemical induction. 
Using lasers, light can be applied with very tight spatial resolution in living cells and 
animals, and it can be rapidly turned on and off. In an early example of light-mediated 
control, an NLS peptide was synthesized with a critical lysine modified with a 
photocleavable group sensitive to UV light [62]. The modified NLS was conjugated to 
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BSAin vitro and then microinjected into cells. Only after UV stimulation could the NLS 
bind to importins, and recruit BSA to the nucleus. More recently, to avoid the need for 
microinjection, a genetically encoded system was developed for expression of caged lysines 
and used to activate a NLS fused to a transcription factor (Figure 1). This approach is not 
reversible and requires special expression systems for the caged lysine [63].
Another UV light-based approach consists in using the Arabidopsis thaliana UVR8 
photoreceptor which binds to the E3 ubiquitin ligase COP1 after irradiation with UV-B light 
(280–315 nm) [64,65]. The basic idea behind this approach is very similar to the one that 
characterizes rapamycin-based methods: one of the two components should reside inside the 
nucleus the whole time, while the other component fused to the POI should be mostly 
cytoplasmic but still shuttling inside the nucleus where it can find its binding partner, in this 
case after illumination with UV-B light. When testing accumulation of GFP fused to UVR8, 
Crefcoeur and colleagues observe slow kinetics of nuclear accumulation [66]. Kinetics 
might get slower for a POI larger than GFP [67–69]. This system is irreversible, therefore it 
is mostly suited for applications where the protein to be light-controlled has an all-or-none 
function (e.g. Cre recombinase). In this case, import kinetics are likely less critical.
Reversible control
Methods based on the red/far-red responsive PhyB-PIF system: The plant phytochrome 
B (PhyB) exists in three conformations: 1) the apo-form not bound to the chromophore 
phycocyanobilin (PCB); 2) the chromophore-bound, red light absorbing Pr conformation, 
which is biologically inactive; and 3) the chromophore-bound, infrared absorbing Pfr 
conformation, which is active [70]. PhyB in the Pfr form interacts with phytochrome 
interacting factors (PIFs) and the interaction is released by infrared illumination, which 
brings PhyB back to its red-absorbing, non-PIF binding Pr state [71]. This light-dependent 
complex formation has been successfully used in the engineering of optogenetic control of 
protein-protein interactions [72–76]. More recently the system has been adapted to 
specifically control nuclear translocation. There are two slightly different versions of PhyB-
PIF-mediated nuclear translocation.
In one version, developed by Yang and co-workers for usage in budding yeast, PhyB is 
either anchored to the nucleus by means of a fusion to the histone H2B or kept nuclear by 
means of fusion to a NLS [77]. The POI is fused to a fragment of PIF6 (aa 1–100) and is 
equally distributed between cytoplasm and nucleus. Nuclear localization is likely due to the 
presence of a weak NLS on PIF. Once red light is shone on the cells, PhyB and PIF interact, 
thereby causing the retention of the POI in the nucleus. This method has been shown to 
work with fluorescent proteins of various sizes (e.g. mCitrine, GFP-GFP or Venus-Venus-
Venus) and with the biologically relevant protein cyclin Clb2. Using their optogenetic 
system, the authors investigated interesting aspects of Clb2 biology, such as the time during 
the cell cycle at which it is needed for nuclear fission. Importantly, this tool is not restricted 
to nuclear localization, as by simply selecting another type of anchor the POI can be 
recruited to various cellular addresses, including small organelles such as the spindle pole 
body, peroxisomes and the nucleolus. Indeed, by choosing the plasma membrane as anchor, 
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the POI can be depleted from the nucleus, effectively producing an optogenetic version of 
techniques based on chemically induced dimerization.
In another variation developed by Beyer and co-workers for use in mammalian cells, the POI 
is fused to PhyB and can contain a NES to allow return of the fusion protein to the 
cytoplasm after nuclear localization (without additional NES the fusion protein is trapped in 
the nucleus and the tool is, thus, irreversible [78]). The PIF used here is the full length PIF3 
from Arabidopsis thaliana. The authors take advantage of the biology of the system, 
whereby PhyB gets translocated in the nucleus by virtue of its interaction with PIF3 under 
red light [78] (Figure 1). This system has been used to control gene expression in 
mammalian cells and zebrafish using a synthetic transcription factor based on the TetR 
binding domain and the VP16 transactivation domain.
Both approaches based on the PhyB-PIF system share many properties. First of all, there is 
no light absorption (and therefore complex formation) until the PCB chromophore is added, 
which provides a tight off state for the start of experiments. When addition of the 
chromophore is not a problem –e.g. in cell culture or at the early stages of development in 
zebrafish larvae (when done by injection) – these methods are quite advantageous. However, 
having to externally add the chromophore mitigates other advantages of red light, i.e. its 
deeper penetration into tissue, making the use of the PhyB-PIF system in animals for 
instance more challenging. While production of PCB by Chinese hamster ovary cells has 
been established by introducing two enzymes that convert heme into PCB [79], the question 
remains whether adopting the same strategy in animals would be possible given that heme is 
a very important cofactor in many reactions, among which cellular respiration.
The interaction between PhyB and PIF can be quickly disrupted at any time point by shining 
infrared light onto the cells, meaning that the tools have a high temporal resolution, only 
limited by nucleocytoplasmic transport itself. Reversibility is, though, obtained at the cost of 
equipping the microscope with a filter set or laser for infrared light. Finally, these methods 
are based on two components and, therefore, the concentration of each one needs to be 
carefully titrated to achieve quantitative control of protein nuclear accumulation kinetics.
Methods based on the blue light responsive LOV2 domain of Avena sativa: Light 
Oxygen Voltage (LOV) domains are protein domains that sense changes in oxygen, redox 
potential and light in cells [80,81]. The second LOV domain of Avena sativa phototrophin 1 
(As LOV2) has been extensively used for creating optogenetic switches because it is small, 
binds a chromophore that is abundant in nature (Flavin Mononucelotide, FMN), and 
undergoes a well characterized structural transition with blue light stimulation that can be 
harnessed to regulate protein-protein interactions and protein function (see Box 1 for more 
details).
Recently, methods to control nuclear protein import and export with the As LOV2 domain 
have been developed [82,83,86,87] (Figure 1). These methods all control the accessibility of 
engineered NLSs and NESs by embedding them in the Jα helix of As LOV2 so that they are 
more exposed when the Jα helix undocks from the rest of the protein in the lit state (Box 1 
and Figure 2a). Interestingly, the tools for import (LINuS and LANS), as well as those for 
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export (LEXY and LINX), were independently developed in two laboratories, providing 
evidence that this approach is robust, can be used on different proteins, in several cell lines 
and animals, and for different biological applications.
One useful feature of these systems is that they are single-component (Figure 2 b–d). The 
POI is fused to the modified As LOV2 (which is as small as GFP) bearing either a caged 
NLS (LINuS and LANS) or NES (LEXY and LINX), and is expressed in cells. In the 
presence of blue light, the exposed NLS/NES interacts with the endogenous import/export 
machinery triggering accumulation of the fusion protein in the nucleus/cytoplasm (Figure 2). 
These methods have been used to control entry into mitosis [87], gene expression from 
synthetic [82,83,86,87] or natural transcription factors such as p53 [86] and an E3 ubiquitin 
ligase that modifies histone H2B in yeast [82]. In the latter study, rapid removal of the E3 
ligase from the nucleus allowed the investigators to monitor the in vivo stability of the 
monoubiquitylated H2B. Surprisingly, the modification was removed within two minutes, 
highlighting the dynamic nature of epigenetic modifications and demonstrating the 
usefulness of light-activated tools for studying dynamic processes.
Methods based on the LOV2 domain suffer from the problem of “leakiness”, i.e. activation 
of the system prior to illumination. This is due to the fact that the LOV2 domain always 
exists in its two conformations and light only shifts the equilibrium towards the lit state [94]. 
This means that, even in the dark, there is always some spontaneous uncaging of the 
NLS/NES with consequential import/export of the fusion protein. To compensate for this, 
Niopek and colleagues, and Yumerefendi and colleagues added a constitutively exposed 
countersignal –that is, a NES for their import tools and a NLS for their export tools –to 
ensure that the fusion protein rapidly returns to the appropriate compartment in the dark 
state. Notably, such additional sequences might not be necessary when the POI already 
contains them. Interestingly, these tools can also be used in combination with other 
optogenetic switches; for instance, by using the LYNX switch in tandem with a light-
induced dimer that recruited the LYNX-POI fusion to the mitochondria in the light, the 
authors further reduced nuclear levels in the lit state [82]. In another example, the tools for 
nuclear import and export were combined to control with the same light pulse the movement 
of two fluorescent proteins in opposing directions [86]. One attractive feature of As LOV2-
based systems is that the FMN chromophore is endogenously made by all cell types, readily 
allowing experiments in animals [96]. The shallow tissue penetration of blue light can be 
bypassed for example by using upconversion nanoparticles (UCNPs) which convert near-
infrared light into visible light [97–100].
Opto-LMB: Niopek and colleagues also created a different version of their export LEXY 
tool which effectively corresponds to a light-inducible LMB treatment (the authors call it 
Opto-LMB). By fusing the engineered As LOV2-NES domain to histone H2B, their 
anchored a light-inducible CRM1 “sponge” into the nucleus. When cells are illuminated 
with blue light, the NES gets exposed binding the endogenous export receptors, making 
them unavailable to bind to and export other cargos [86]. Albeit being less tight than LMB 
itself, Opto-LMB is genetically encoded and fully reversible, thus problems arising from 
LMB toxicity can be avoided. Moreover, as NESs of different strengths can be caged within 
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the LOV2 domain, this tool can be tuned to block the export of a subset of endogenous 
targets.
Conclusion and outlook
Since many biological processes are controlled by the timely translocation of proteins in or 
out of the nucleus, being able to induce such translocation with an external trigger is very 
important for cell biological studies. Nowadays, this is possible with the tools presented 
here, among which cell biologists can find the one most suited for the specific application 
(Table 1). Still, in most cases, optimization of the selected switch is required to obtain 
optimal results with the POI in any given cellular system (see for instance [102]).
While many studies are conducted with overexpressed proteins (i.e. transient transfection of 
plasmid-bore engineered construct in cells), modern genome-engineering techniques such as 
CRISPR/Cas [103] will allow for more studies with protein expressed from their 
endogenous locus. In this case, single-component tools are advantageous requiring only 
appending the photoswitch to either terminus of the POI. Notably, Yumerefendi and 
colleagues demonstrated that LANS functioned when integrated in the genome of C. elegans 
[83].
Finally, a challenge for the future will be to find ways to directly control the localization of 
unmodified, endogenous proteins. We speculate that combining the switches presented here 
with engineered peptides or proteins [104] that bind with high specificity and affinity their 
targets is a promising strategy in this direction.
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Box 1
Using the AsLOV2 domain to regulate peptide-protein interactions. Several studies 
have demonstrated that the LOV2 domain from Avena sativa phototropin 1 (As LOV2) 
can be used to effectively cage peptides so that they have reduced affinity for their 
binding partners in the dark, but binding is restored in the light [82–90]. This change in 
binding affinity can be used to regulate a variety of cellular processes including nuclear 
import and export. As LOV2 binds a flavin mononucleotide (FMN) in the center of the 
protein. Upon irradiation with blue light, a metastable covalent bond is formed between a 
cysteine in the core of the protein and a carbon atom of the FMN [91]. NMR studies 
indicate that this leads to large conformational changes in the protein, including 
undocking and unfolding of the C-terminal helix of the protein (the Jα helix) [92]. When 
the light is turned off, the metastable bond breaks within seconds to hours, depending on 
the LOV domain ortholog (for As LOV2 the reversion time is ~30 sec.) [93], and the the 
Jα helix refolds. It is important to point out that the changes to the Jα helix between the 
lit and dark state are not an all or none process, but rather there is always an equilibrium 
between the docked/folded state and the undocked/unfolded state. For wild type As 
LOV2 the docked/undocked ratio is 98.4/1.6 In the dark and 9/91 in the lit state [94]. The 
sequence alignment shows the various positions at which investigators have placed 
peptides of interest (underlined residues) in the As LOV2 to achieve light sensitivity. In 
order to achieve caging in the dark it is important to have at least a few critical residues 
from the peptide embedded in the last helical turn of the Jα helix. In creating the 
chimeric sequences, it is also important to conserve the hydrophobicity of the Jα residues 
that are packed against the core of the domain. The crystal structure shown here is of the 
As LOV2 domain with the SsrA peptide embedded in the Jα helix [90]. This construct 
also includes an engineered phenylalanine at the end of the Jα helix that packs back 
against the domain and further holds the dark state closed. Other Jα helix mutations have 
also been discovered that stabilize the closed state of the protein, and can be used to 
improve switching [95].
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Highlights
• Protein localization regulates function
• Gene expression is controlled by nuclear localization of transcriptional 
regulators
• The basic signals dictating nuclear import and export have been 
deciphered
• Small molecules can be used to control nuclear transport of engineered 
proteins
• Light-activatable proteins can provide reversible control of nuclear 
localization
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Figure 1. 
Overview of methods for external control of nuclear protein localization. For simplicity, only 
some of the methods are depicted here. Different color zones correspond to different 
methods. The selected colors roughly indicate the wavelengths used for illumination: UV 
light for uncaging lysines, blue light to activate the LOV domain and red/infrared light to 
activate/de-activate the PhyB/PIF system. Numbers indicate temporally sequential events. In 
the case of the lysine caged with a photo-removable protective group, the cargo is depicted 
with a small black tongue, to indicate the presence of the unnatural amino acid. NCP: 
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nuclear pore complex; FRB: FKBP and rapamycin binding domain; As LOV2: Avena sativa 
LOV2 domain from phototrophin 1; PhyB: phytochrome B; PIF: phytochrome interacting 
factor.
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Figure 2. 
As LOV2-based methods for controlling import and export. (a) Schematic drawing showing 
the conformational change of As LOV2 upon light absorption leading to Jα helix undocking 
and unfolding and consequential exposure of NLS/NES motifs. This mechanism is common 
to LINuS, LANS, LEXY and LINX. (b–d) Upper panel: schematic drawing of the construct. 
Thin black line, flexible linker. (b) Representative images of HEK 293T cells expressing 
NES-mCherry-LINuS before and after blue light illumination. Scale bar, 15 µm. LINuS here 
is the biLINuS22 variant. NES, PKIt NES. (c) Representative images of a C. elegans embryo 
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before and after blue light illumination. Scale bar, 10 µm. LANS here is the variant LANS4. 
(d) Representative images of HEK 293T cells (left) and mouse fibroblasts (IA32) cells 
(right) transfected with the indicated construct before and after blue illumination. Scale bar, 
20 µm (left) and 50 µm (right).
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Table 1
Methods for Inducible Control of Nuclear Localization
System/
Molecule Engineered Function Critical Features
Selected
References
Chemical
Induction
Leptomycin B
(LMB)
Broad inhibitor of
nuclear export
Covalent inhibitor of CRM1
Non-reversible [36]
Fusions with
nuclear
receptors
Ligand binding induces
nuclear import
Estrogen, Glucocorticoid,
and Progesterone
receptors have been used
Commonly used to control
Cre recombinase
One-component system
[39] [40]
Rapamycin-
dependent
dimerization
Protein of interest
recruited to cytosolic
or nuclear proteins via
dimerization
Common technique in
yeast (“anchor away”)
Requires rapamycin-
resistant yeast strain
Non-reversible inhibition in
<15 minutes
Two-component system
[49–53]
Light
Induction
Photocaged
lysine in a NLS
Inducible nuclear
import of fusion
proteins
Non-reversible / UV-light
sensitive
Requires cells engineered
for use with non-natural
amino acids
One-component system
[62,63]
PhyB/PIF
dimerization
Inducible nuclear
import or export of
fusion proteins
Reversible: 650 nm ->
PhyB/PIF complex forms,
750 nm -> PhyB/PIF
complex dissociates
Very tight spatio-temporal
control
Chromophore must be
supplied in non-plant
systems
Two-component system
[77,78,101]
Caging of NLS
with AsLOV2
Inducible nuclear
import of fusion
proteins
Reversible: 450 nm ->
nucleus, dark -> cytoplasm
Chromophore abundant in
most systems
One-component system
[83,87]
Caging of NES
with AsLOV2
Inducible nuclear
export of fusion
proteins
Reversible: 450 nm ->
cytoplasm, dark -> nucleus
Chromophore abundant in
most systems
One-component system
[82,86]
UVR8
dimerization
with COP1/NLS
Inducible nuclear
import of fusion
proteins.
UV-B light sensitive
Slower than other systems
(responds in minutes to
hours); Two-component
system
[66]
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